Moreover, ANXA1 has been reported to have therapeutic potential in ischemia-reperfusion injury (Ansari et al., 2018) and protecting against the breakdown of the blood-brain barrier in AD (Park et al., 2017). Here, ANXA1 is linked to Alzheimer disease.